Vitamin B Complex for Sensorineural Hearing Loss
Vitamin B complex is not recommended as a treatment for sensorineural hearing loss, as there is no high-quality evidence supporting its efficacy, and established guidelines do not include it in the treatment algorithm. 1
Evidence-Based Treatment Recommendations
The American Academy of Otolaryngology-Head and Neck Surgery provides clear guidance on managing sensorineural hearing loss, and vitamin B complex is notably absent from these recommendations 1:
Primary Treatment Approach
Oral corticosteroids within 2 weeks of symptom onset represent the only evidence-based initial therapy for sudden sensorineural hearing loss (SSNHL), with the best outcomes achieved when treatment begins early 1, 2
Intratympanic steroid therapy should be offered as salvage treatment between 2-6 weeks after symptom onset if incomplete recovery occurs with initial oral steroids 1, 2
Hyperbaric oxygen therapy combined with steroids may be considered as either initial treatment (within 2 weeks) or salvage therapy (within 1 month), but only when used in combination with corticosteroids 1
What the Guidelines Explicitly Recommend Against
The American Academy of Otolaryngology-Head and Neck Surgery specifically removed antioxidants from their list of recommended interventions in their 2019 update, indicating lack of supporting evidence for nutritional supplements in general 1
Limited Evidence on B Vitamins
Vitamin B12 Specifically
While some observational data suggests associations between vitamin B12 deficiency and hearing impairment, the evidence does not support routine supplementation for treatment 3:
A 2025 systematic review found that individuals with lower B12 levels had higher prevalence of hearing impairment, but this represents correlation, not causation 3
One small 1983 study on B12 supplementation for tinnitus showed no significant improvement in tinnitus severity, and hearing improvement was only observed at 250 Hz frequency in some patients—not clinically meaningful 4
The only established indication for high-dose vitamin B12 in hearing contexts is when B12 deficiency with neurological involvement is confirmed, requiring hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, then every 2 months for maintenance 1
Other Vitamins
Vitamin D deficiency has been associated with bilateral sensorineural hearing loss in observational studies, but no treatment trials demonstrate efficacy 5, 6, 7
Fat-soluble vitamins (A, D, E) showed lower serum levels in SSNHL patients in one 2023 study, but this does not establish causation or treatment benefit 7
Critical Clinical Pitfalls to Avoid
Do not delay proven corticosteroid therapy while pursuing unproven vitamin supplementation, as the window for effective treatment closes rapidly after 2 weeks 1, 2
Do not assume vitamin supplementation can substitute for proper diagnostic workup, including audiometry within 14 days and MRI with dedicated internal auditory canal protocol to exclude retrocochlear pathology 1, 8, 2
Do not order routine laboratory testing (including vitamin levels) for SSNHL unless systemic illness is suspected, as these have low diagnostic yield and do not change management 1, 8
When B12 Supplementation IS Indicated
The only scenario where high-dose B12 therapy is appropriate in the context of hearing loss 1:
Confirmed vitamin B12 deficiency with neurological involvement (unexplained sensory/motor/gait symptoms): Hydroxocobalamin 1 mg IM on alternate days until no further improvement, then 1 mg IM every 2 months lifelong
Confirmed B12 deficiency without neurological involvement: Hydroxocobalamin 1 mg IM three times weekly for 2 weeks, then 1 mg IM every 2-3 months lifelong
This requires documented B12 deficiency on laboratory testing, not empiric supplementation 1
Recommended Management Algorithm
For any patient presenting with sensorineural hearing loss 1, 8, 2:
- Confirm SNHL with audiometry (distinguish from conductive hearing loss) within 14 days of symptom onset
- Initiate oral corticosteroids immediately if within 2 weeks of onset
- Order MRI with dedicated IAC protocol to exclude retrocochlear pathology (not routine CT head or laboratory tests)
- Reassess at 2-6 weeks: If incomplete recovery, offer intratympanic steroid salvage therapy
- Follow-up audiometry at treatment conclusion and within 6 months
- Audiologic rehabilitation (hearing aids, counseling) for residual hearing loss or tinnitus
Vitamin B complex has no role in this algorithm unless specific B12 deficiency with neurological symptoms is documented.